Science, technology and the emergence of AI have converged to make precision medicine for acute care a reality. This is how we deliver healthcare tailored to biology.
Research & Development
Evidence
Clinical Trials
The Sepsis ImmunoScore® Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available Biomarkers
Read More →
Prenosis is developing a pipeline of integrated diagnostics and therapeutics grounded in each patient's unique biological profile, using deep data science and AI to give clinicians tools that reflect the true complexity of critical disease.
Immunix®
Sepsis ImmunoScore®
BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease
Read More →
Blogs, articles, videos, and podcasts exploring how precision medicine and AI are changing the way clinicians detect and treat critical conditions.
Resource Library
Events
Treating the Patient, Not the Disease
Read More →
Read the latest Prenosis peer-reviewed articles and items from scholarly journals.
Newsroom
Sepsis ImmunoScore Outperforms Conventional Sepsis Tools
Read More →
As a biology-based technology company, we combine data science with AI to transform how critical conditions are diagnosed and treated.
Mission, Vision & Values
Careers
Leadership
Awards
LifeBridge Health deploys Prenosis’ FDA-authorized AI tool to speed sepsis detection
Read More →
Release originally posted on HIT Consultant
The Chicago-based health tech company Prenosis revealed a dual milestone: the closing of a $20M Series A financing round and the awarding of a $20M contract from the Biomedical Advanced Research and Development Authority (BARDA). This combined $40M war chest positions Prenosis to move beyond simple diagnostics and into the realm of “precision critical care.”
Read full release >